APO Research, Inc.

APO RESEARCH · REPORT

Medical Sevoflurane

Selected research

Market Analysis & Forecast

Global Medical Sevoflurane Market Analysis and Forecast 2026-2032

Market perspective

The global Medical Sevoflurane market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Medical Sevoflurane is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Medical Sevoflurane is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Medical Sevoflurane is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Medical Sevoflurane is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Medical Sevoflurane include AbbVie, Maruishi, Piramal, PT Novell Pharmaceutical, Viatris, Baxter, Lunan Pharma and Hengrui, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Medical Sevoflurane, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Medical Sevoflurane, also provides the sales of main regions and countries. Of the upcoming market potential for Medical Sevoflurane, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Medical Sevoflurane sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Medical Sevoflurane market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Medical Sevoflurane sales, projected growth trends, production technology, application and end-user industry.

Medical Sevoflurane Segment by Company

AbbVie

Maruishi

Piramal

PT Novell Pharmaceutical

Viatris

Baxter

Lunan Pharma

Hengrui

Medical Sevoflurane Segment by Type

250ml/Bottle

120ml/Bottle

Other

Medical Sevoflurane Segment by Application

Children

Adults

Medical Sevoflurane Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Medical Sevoflurane market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Medical Sevoflurane and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Medical Sevoflurane.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Medical Sevoflurane in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Medical Sevoflurane manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Medical Sevoflurane sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Medical Sevoflurane Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. 250ml/Bottle Major Manufacturers Table 3. 120ml/Bottle Major Manufacturers Table 4. Other Major Manufacturers Table 5. Global Medical Sevoflurane Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Children Major Manufacturers Table 7. Adults Major Manufacturers Table 8. Medical Sevoflurane Industry Trends Table 9. Medical Sevoflurane Industry Drivers Table 10. Medical Sevoflurane Industry Opportunities and Challenges Table 11. Medical Sevoflurane Industry Restraints Table 12. Global Medical Sevoflurane Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 13. Global Medical Sevoflurane Revenue by Region (2021-2026) & (US$ Million) Table 14. Global Medical Sevoflurane Revenue by Region (2027-2032) & (US$ Million) Table 15. Global Medical Sevoflurane Revenue Market Share by Region (2021-2026) Table 16. Global Medical Sevoflurane Revenue Market Share by Region (2027-2032) Table 17. Global Medical Sevoflurane Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 18. Global Medical Sevoflurane Sales by Region (2021-2026) & (K Units) Table 19. Global Medical Sevoflurane Sales by Region (2027-2032) & (K Units) Table 20. Global Medical Sevoflurane Sales Market Share by Region (2021-2026) Table 21. Global Medical Sevoflurane Sales Market Share by Region (2027-2032) Table 22. Global Medical Sevoflurane Revenue by Manufacturers (US$ Million) & (2021-2026) Table 23. Global Medical Sevoflurane Revenue Market Share by Manufacturers (2021-2026) Table 24. Global Medical Sevoflurane Sales by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Medical Sevoflurane Sales Market Share by Manufacturers (2021-2026) Table 26. Global Medical Sevoflurane Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 27. Global Medical Sevoflurane Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 28. Global Medical Sevoflurane Key Manufacturers Manufacturing Sites & Headquarters Table 29. Global Medical Sevoflurane Manufacturers, Product Type & Application Table 30. Global Medical Sevoflurane Manufacturers' Establishment Date Table 31. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 32. Global Medical Sevoflurane by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 33. Global Medical Sevoflurane Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Medical Sevoflurane Revenue by Type (2021-2026) & (US$ Million) Table 35. Global Medical Sevoflurane Revenue by Type (2027-2032) & (US$ Million) Table 36. Global Medical Sevoflurane Revenue Market Share by Type (2021-2026) Table 37. Global Medical Sevoflurane Revenue Market Share by Type (2027-2032) Table 38. Global Medical Sevoflurane Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 39. Global Medical Sevoflurane Sales by Type (2021-2026) & (K Units) Table 40. Global Medical Sevoflurane Sales by Type (2027-2032) & (K Units) Table 41. Global Medical Sevoflurane Sales Market Share by Type (2021-2026) Table 42. Global Medical Sevoflurane Sales Market Share by Type (2027-2032) Table 43. Global Medical Sevoflurane Price by Type (2021-2026) & (US$/Unit) Table 44. Global Medical Sevoflurane Price by Type (2027-2032) & (US$/Unit) Table 45. Global Medical Sevoflurane Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 46. Global Medical Sevoflurane Revenue by Application (2021-2026) & (US$ Million) Table 47. Global Medical Sevoflurane Revenue by Application (2027-2032) & (US$ Million) Table 48. Global Medical Sevoflurane Revenue Market Share by Application (2021-2026) Table 49. Global Medical Sevoflurane Revenue Market Share by Application (2027-2032) Table 50. Global Medical Sevoflurane Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 51. Global Medical Sevoflurane Sales by Application (2021-2026) & (K Units) Table 52. Global Medical Sevoflurane Sales by Application (2027-2032) & (K Units) Table 53. Global Medical Sevoflurane Sales Market Share by Application (2021-2026) Table 54. Global Medical Sevoflurane Sales Market Share by Application (2027-2032) Table 55. Global Medical Sevoflurane Price by Application (2021-2026) & (US$/Unit) Table 56. Global Medical Sevoflurane Price by Application (2027-2032) & (US$/Unit) Table 57. AbbVie Company Information Table 58. AbbVie Business Overview Table 59. AbbVie Medical Sevoflurane Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 60. AbbVie Medical Sevoflurane Product Portfolio Table 61. AbbVie Recent Development Table 62. Maruishi Company Information Table 63. Maruishi Business Overview Table 64. Maruishi Medical Sevoflurane Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 65. Maruishi Medical Sevoflurane Product Portfolio Table 66. Maruishi Recent Development Table 67. Piramal Company Information Table 68. Piramal Business Overview Table 69. Piramal Medical Sevoflurane Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 70. Piramal Medical Sevoflurane Product Portfolio Table 71. Piramal Recent Development Table 72. PT Novell Pharmaceutical Company Information Table 73. PT Novell Pharmaceutical Business Overview Table 74. PT Novell Pharmaceutical Medical Sevoflurane Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. PT Novell Pharmaceutical Medical Sevoflurane Product Portfolio Table 76. PT Novell Pharmaceutical Recent Development Table 77. Viatris Company Information Table 78. Viatris Business Overview Table 79. Viatris Medical Sevoflurane Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Viatris Medical Sevoflurane Product Portfolio Table 81. Viatris Recent Development Table 82. Baxter Company Information Table 83. Baxter Business Overview Table 84. Baxter Medical Sevoflurane Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Baxter Medical Sevoflurane Product Portfolio Table 86. Baxter Recent Development Table 87. Lunan Pharma Company Information Table 88. Lunan Pharma Business Overview Table 89. Lunan Pharma Medical Sevoflurane Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Lunan Pharma Medical Sevoflurane Product Portfolio Table 91. Lunan Pharma Recent Development Table 92. Hengrui Company Information Table 93. Hengrui Business Overview Table 94. Hengrui Medical Sevoflurane Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Hengrui Medical Sevoflurane Product Portfolio Table 96. Hengrui Recent Development Table 97. North America Medical Sevoflurane Revenue by Type (2021-2026) & (US$ Million) Table 98. North America Medical Sevoflurane Revenue by Type (2027-2032) & (US$ Million) Table 99. North America Medical Sevoflurane Sales by Type (2021-2026) & (K Units) Table 100. North America Medical Sevoflurane Sales by Type (2027-2032) & (K Units) Table 101. North America Medical Sevoflurane Sales Price by Type (2021-2026) & (US$/Unit) Table 102. North America Medical Sevoflurane Sales Price by Type (2027-2032) & (US$/Unit) Table 103. North America Medical Sevoflurane Revenue by Application (2021-2026) & (US$ Million) Table 104. North America Medical Sevoflurane Revenue by Application (2027-2032) & (US$ Million) Table 105. North America Medical Sevoflurane Sales by Application (2021-2026) & (K Units) Table 106. North America Medical Sevoflurane Sales by Application (2027-2032) & (K Units) Table 107. North America Medical Sevoflurane Sales Price by Application (2021-2026) & (US$/Unit) Table 108. North America Medical Sevoflurane Sales Price by Application (2027-2032) & (US$/Unit) Table 109. North America Medical Sevoflurane Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 110. North America Medical Sevoflurane Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 111. North America Medical Sevoflurane Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 112. North America Medical Sevoflurane Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 113. North America Medical Sevoflurane Sales by Country (2021-2026) & (K Units) Table 114. North America Medical Sevoflurane Sales by Country (2027-2032) & (K Units) Table 115. North America Medical Sevoflurane Sales Price by Country (2021-2026) & (US$/Unit) Table 116. North America Medical Sevoflurane Sales Price by Country (2027-2032) & (US$/Unit) Table 117. United States Medical Sevoflurane Revenue (2021-2032) & (US$ Million) Table 118. Canada Medical Sevoflurane Revenue (2021-2032) & (US$ Million) Table 119. Mexico Medical Sevoflurane Revenue (2021-2032) & (US$ Million) Table 120. Europe Medical Sevoflurane Revenue by Type (2021-2026) & (US$ Million) Table 121. Europe Medical Sevoflurane Revenue by Type (2027-2032) & (US$ Million) Table 122. Europe Medical Sevoflurane Sales by Type (2021-2026) & (K Units) Table 123. Europe Medical Sevoflurane Sales by Type (2027-2032) & (K Units) Table 124. Europe Medical Sevoflurane Sales Price by Type (2021-2026) & (US$/Unit) Table 125. Europe Medical Sevoflurane Sales Price by Type (2027-2032) & (US$/Unit) Table 126. Europe Medical Sevoflurane Revenue by Application (2021-2026) & (US$ Million) Table 127. Europe Medical Sevoflurane Revenue by Application (2027-2032) & (US$ Million) Table 128. Europe Medical Sevoflurane Sales by Application (2021-2026) & (K Units) Table 129. Europe Medical Sevoflurane Sales by Application (2027-2032) & (K Units) Table 130. Europe Medical Sevoflurane Sales Price by Application (2021-2026) & (US$/Unit) Table 131. Europe Medical Sevoflurane Sales Price by Application (2027-2032) & (US$/Unit) Table 132. Europe Medical Sevoflurane Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 133. Europe Medical Sevoflurane Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 134. Europe Medical Sevoflurane Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 135. Europe Medical Sevoflurane Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 136. Europe Medical Sevoflurane Sales by Country (2021-2026) & (K Units) Table 137. Europe Medical Sevoflurane Sales by Country (2027-2032) & (K Units) Table 138. Europe Medical Sevoflurane Sales Price by Country (2021-2026) & (US$/Unit) Table 139. Europe Medical Sevoflurane Sales Price by Country (2027-2032) & (US$/Unit) Table 140. Germany Medical Sevoflurane Revenue (2021-2032) & (US$ Million) Table 141. France Medical Sevoflurane Revenue (2021-2032) & (US$ Million) Table 142. U.K. Medical Sevoflurane Revenue (2021-2032) & (US$ Million) Table 143. Italy Medical Sevoflurane Revenue (2021-2032) & (US$ Million) Table 144. Russia Medical Sevoflurane Revenue (2021-2032) & (US$ Million) Table 145. Spain Medical Sevoflurane Revenue (2021-2032) & (US$ Million) Table 146. Netherlands Medical Sevoflurane Revenue (2021-2032) & (US$ Million) Table 147. Switzerland Medical Sevoflurane Revenue (2021-2032) & (US$ Million) Table 148. Sweden Medical Sevoflurane Revenue (2021-2032) & (US$ Million) Table 149. Poland Medical Sevoflurane Revenue (2021-2032) & (US$ Million) Table 150. China Medical Sevoflurane Revenue by Type (2021-2026) & (US$ Million) Table 151. China Medical Sevoflurane Revenue by Type (2027-2032) & (US$ Million) Table 152. China Medical Sevoflurane Sales by Type (2021-2026) & (K Units) Table 153. China Medical Sevoflurane Sales by Type (2027-2032) & (K Units) Table 154. China Medical Sevoflurane Sales Price by Type (2021-2026) & (US$/Unit) Table 155. China Medical Sevoflurane Sales Price by Type (2027-2032) & (US$/Unit) Table 156. China Medical Sevoflurane Revenue by Application (2021-2026) & (US$ Million) Table 157. China Medical Sevoflurane Revenue by Application (2027-2032) & (US$ Million) Table 158. China Medical Sevoflurane Sales by Application (2021-2026) & (K Units) Table 159. China Medical Sevoflurane Sales by Application (2027-2032) & (K Units) Table 160. China Medical Sevoflurane Sales Price by Application (2021-2026) & (US$/Unit) Table 161. China Medical Sevoflurane Sales Price by Application (2027-2032) & (US$/Unit) Table 162. Asia Medical Sevoflurane Revenue by Type (2021-2026) & (US$ Million) Table 163. Asia Medical Sevoflurane Revenue by Type (2027-2032) & (US$ Million) Table 164. Asia Medical Sevoflurane Sales by Type (2021-2026) & (K Units) Table 165. Asia Medical Sevoflurane Sales by Type (2027-2032) & (K Units) Table 166. Asia Medical Sevoflurane Sales Price by Type (2021-2026) & (US$/Unit) Table 167. Asia Medical Sevoflurane Sales Price by Type (2027-2032) & (US$/Unit) Table 168. Asia Medical Sevoflurane Revenue by Application (2021-2026) & (US$ Million) Table 169. Asia Medical Sevoflurane Revenue by Application (2027-2032) & (US$ Million) Table 170. Asia Medical Sevoflurane Sales by Application (2021-2026) & (K Units) Table 171. Asia Medical Sevoflurane Sales by Application (2027-2032) & (K Units) Table 172. Asia Medical Sevoflurane Sales Price by Application (2021-2026) & (US$/Unit) Table 173. Asia Medical Sevoflurane Sales Price by Application (2027-2032) & (US$/Unit) Table 174. Asia Medical Sevoflurane Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 175. Asia Medical Sevoflurane Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 176. Asia Medical Sevoflurane Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 177. Asia Medical Sevoflurane Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 178. Asia Medical Sevoflurane Sales by Country (2021-2026) & (K Units) Table 179. Asia Medical Sevoflurane Sales by Country (2027-2032) & (K Units) Table 180. Asia Medical Sevoflurane Sales Price by Country (2021-2026) & (US$/Unit) Table 181. Asia Medical Sevoflurane Sales Price by Country (2027-2032) & (US$/Unit) Table 182. Japan Medical Sevoflurane Revenue (2021-2032) & (US$ Million) Table 183. South Korea Medical Sevoflurane Revenue (2021-2032) & (US$ Million) Table 184. India Medical Sevoflurane Revenue (2021-2032) & (US$ Million) Table 185. Australia Medical Sevoflurane Revenue (2021-2032) & (US$ Million) Table 186. Taiwan Medical Sevoflurane Revenue (2021-2032) & (US$ Million) Table 187. Southeast Asia Medical Sevoflurane Revenue (2021-2032) & (US$ Million) Table 188. SAMEA Medical Sevoflurane Revenue by Type (2021-2026) & (US$ Million) Table 189. SAMEA Medical Sevoflurane Revenue by Type (2027-2032) & (US$ Million) Table 190. SAMEA Medical Sevoflurane Sales by Type (2021-2026) & (K Units) Table 191. SAMEA Medical Sevoflurane Sales by Type (2027-2032) & (K Units) Table 192. SAMEA Medical Sevoflurane Sales Price by Type (2021-2026) & (US$/Unit) Table 193. SAMEA Medical Sevoflurane Sales Price by Type (2027-2032) & (US$/Unit) Table 194. SAMEA Medical Sevoflurane Revenue by Application (2021-2026) & (US$ Million) Table 195. SAMEA Medical Sevoflurane Revenue by Application (2027-2032) & (US$ Million) Table 196. SAMEA Medical Sevoflurane Sales by Application (2021-2026) & (K Units) Table 197. SAMEA Medical Sevoflurane Sales by Application (2027-2032) & (K Units) Table 198. SAMEA Medical Sevoflurane Sales Price by Application (2021-2026) & (US$/Unit) Table 199. SAMEA Medical Sevoflurane Sales Price by Application (2027-2032) & (US$/Unit) Table 200. SAMEA Medical Sevoflurane Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 201. SAMEA Medical Sevoflurane Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 202. SAMEA Medical Sevoflurane Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 203. SAMEA Medical Sevoflurane Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 204. SAMEA Medical Sevoflurane Sales by Country (2021-2026) & (K Units) Table 205. SAMEA Medical Sevoflurane Sales by Country (2027-2032) & (K Units) Table 206. SAMEA Medical Sevoflurane Sales Price by Country (2021-2026) & (US$/Unit) Table 207. SAMEA Medical Sevoflurane Sales Price by Country (2027-2032) & (US$/Unit) Table 208. Brazil Medical Sevoflurane Revenue (2021-2032) & (US$ Million) Table 209. Argentina Medical Sevoflurane Revenue (2021-2032) & (US$ Million) Table 210. Chile Medical Sevoflurane Revenue (2021-2032) & (US$ Million) Table 211. Colombia Medical Sevoflurane Revenue (2021-2032) & (US$ Million) Table 212. Peru Medical Sevoflurane Revenue (2021-2032) & (US$ Million) Table 213. Saudi Arabia Medical Sevoflurane Revenue (2021-2032) & (US$ Million) Table 214. Israel Medical Sevoflurane Revenue (2021-2032) & (US$ Million) Table 215. UAE Medical Sevoflurane Revenue (2021-2032) & (US$ Million) Table 216. Turkey Medical Sevoflurane Revenue (2021-2032) & (US$ Million) Table 217. Iran Medical Sevoflurane Revenue (2021-2032) & (US$ Million) Table 218. Egypt Medical Sevoflurane Revenue (2021-2032) & (US$ Million) Table 219. Key Raw Materials Table 220. Raw Materials Key Suppliers Table 221. Medical Sevoflurane Distributors List Table 222. Medical Sevoflurane Customers List Table 223. Research Programs/Design for This Report Table 224. Authors List of This Report Table 225. Secondary Sources Table 226. Primary Sources List of Figures Figure 1. Medical Sevoflurane Image Figure 2. Global Medical Sevoflurane Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Medical Sevoflurane Market Size Share 2021 VS 2025 VS 2032 Figure 4. 250ml/Bottle Image Figure 5. 120ml/Bottle Image Figure 6. Other Image Figure 7. Global Medical Sevoflurane Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Medical Sevoflurane Market Size Share 2021 VS 2025 VS 2032 Figure 9. Children Image Figure 10. Adults Image Figure 11. Global Medical Sevoflurane Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Medical Sevoflurane Revenue (2021-2032) & (US$ Million) Figure 13. Global Medical Sevoflurane Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 14. Global Medical Sevoflurane Revenue Market Share by Region: 2025 Versus 2032 Figure 15. Global Medical Sevoflurane Revenue Market Share by Region (2021-2032) Figure 16. Global Medical Sevoflurane Sales (2021-2032) & (K Units) Figure 17. Global Medical Sevoflurane Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 18. Global Medical Sevoflurane Sales Market Share by Region (2021-2032) Figure 19. US & Canada & Mexico Medical Sevoflurane Sales YoY (2021-2032) & (K Units) Figure 20. Europe Medical Sevoflurane Sales YoY (2021-2032) & (K Units) Figure 21. China Medical Sevoflurane Sales YoY (2021-2032) & (K Units) Figure 22. Asia (Excluding China) Medical Sevoflurane Sales YoY (2021-2032) & (K Units) Figure 23. South America, Middle East and Africa Medical Sevoflurane Sales YoY (2021-2032) & (K Units) Figure 24. Global Medical Sevoflurane Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 25. Global Medical Sevoflurane Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 26. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Global Medical Sevoflurane Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Medical Sevoflurane Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 29. Global Medical Sevoflurane Revenue Market Share by Type (2021-2032) Figure 30. Global Medical Sevoflurane Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 31. Global Medical Sevoflurane Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Medical Sevoflurane Sales Market Share by Type (2021-2032) Figure 33. Global Medical Sevoflurane Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global Medical Sevoflurane Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 35. Global Medical Sevoflurane Revenue Market Share by Application (2021-2032) Figure 36. Global Medical Sevoflurane Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 37. Global Medical Sevoflurane Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Medical Sevoflurane Sales Market Share by Application (2021-2032) Figure 39. North America Medical Sevoflurane Revenue Share by Type (2021-2032) Figure 40. North America Medical Sevoflurane Sales Share by Type (2021-2032) Figure 41. North America Medical Sevoflurane Revenue Share by Application (2021-2032) Figure 42. North America Medical Sevoflurane Sales Share by Application (2021-2032) Figure 43. North America Medical Sevoflurane Revenue Share by Country (2021-2032) Figure 44. North America Medical Sevoflurane Sales Share by Country (2021-2032) Figure 45. Europe Medical Sevoflurane Revenue Share by Type (2021-2032) Figure 46. Europe Medical Sevoflurane Sales Share by Type (2021-2032) Figure 47. Europe Medical Sevoflurane Revenue Share by Application (2021-2032) Figure 48. Europe Medical Sevoflurane Sales Share by Application (2021-2032) Figure 49. Europe Medical Sevoflurane Revenue Share by Country (2021-2032) Figure 50. Europe Medical Sevoflurane Sales Share by Country (2021-2032) Figure 51. China Medical Sevoflurane Revenue Share by Type (2021-2032) Figure 52. China Medical Sevoflurane Sales Share by Type (2021-2032) Figure 53. China Medical Sevoflurane Revenue Share by Application (2021-2032) Figure 54. China Medical Sevoflurane Sales Share by Application (2021-2032) Figure 55. Asia Medical Sevoflurane Revenue Share by Type (2021-2032) Figure 56. Asia Medical Sevoflurane Sales Share by Type (2021-2032) Figure 57. Asia Medical Sevoflurane Revenue Share by Application (2021-2032) Figure 58. Asia Medical Sevoflurane Sales Share by Application (2021-2032) Figure 59. Asia Medical Sevoflurane Revenue Share by Country (2021-2032) Figure 60. Asia Medical Sevoflurane Sales Share by Country (2021-2032) Figure 61. SAMEA Medical Sevoflurane Revenue Share by Type (2021-2032) Figure 62. SAMEA Medical Sevoflurane Sales Share by Type (2021-2032) Figure 63. SAMEA Medical Sevoflurane Revenue Share by Application (2021-2032) Figure 64. SAMEA Medical Sevoflurane Sales Share by Application (2021-2032) Figure 65. SAMEA Medical Sevoflurane Revenue Share by Country (2021-2032) Figure 66. SAMEA Medical Sevoflurane Sales Share by Country (2021-2032) Figure 67. Medical Sevoflurane Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Medical Sevoflurane Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • 250ml/Bottle
  • 120ml/Bottle
  • Other
Applications
  • Children
  • Adults
Companies covered
  • AbbVie
  • Maruishi
  • Piramal
  • PT Novell Pharmaceutical
  • Viatris
  • Baxter
  • Lunan Pharma
  • Hengrui

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Medical Sevoflurane Market by Type
  3. 1.2.1 Global Medical Sevoflurane Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 250ml/Bottle
  5. 1.2.3 120ml/Bottle
  6. 1.2.4 Other
  7. 1.3 Medical Sevoflurane Market by Application
  8. 1.3.1 Global Medical Sevoflurane Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Children
  10. 1.3.3 Adults
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Medical Sevoflurane Market Dynamics
  1. 2.1 Medical Sevoflurane Industry Trends
  2. 2.2 Medical Sevoflurane Industry Drivers
  3. 2.3 Medical Sevoflurane Industry Opportunities and Challenges
  4. 2.4 Medical Sevoflurane Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Medical Sevoflurane Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Medical Sevoflurane Revenue by Region
  3. 3.2.1 Global Medical Sevoflurane Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Medical Sevoflurane Revenue by Region (2021-2026)
  5. 3.2.3 Global Medical Sevoflurane Revenue by Region (2027-2032)
  6. 3.2.4 Global Medical Sevoflurane Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Medical Sevoflurane Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Medical Sevoflurane Sales by Region
  9. 3.4.1 Global Medical Sevoflurane Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Medical Sevoflurane Sales by Region (2021-2026)
  11. 3.4.3 Global Medical Sevoflurane Sales by Region (2027-2032)
  12. 3.4.4 Global Medical Sevoflurane Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Medical Sevoflurane Revenue by Manufacturers
  2. 4.1.1 Global Medical Sevoflurane Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Medical Sevoflurane Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Medical Sevoflurane Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Medical Sevoflurane Sales by Manufacturers
  6. 4.2.1 Global Medical Sevoflurane Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Medical Sevoflurane Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Medical Sevoflurane Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Medical Sevoflurane Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Medical Sevoflurane Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Medical Sevoflurane Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Medical Sevoflurane Manufacturers, Product Type & Application
  13. 4.7 Global Medical Sevoflurane Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Medical Sevoflurane Market CR5 and HHI
  16. 4.8.2 2025 Medical Sevoflurane Tier 1, Tier 2, and Tier 3
5 Medical Sevoflurane Market by Type
  1. 5.1 Global Medical Sevoflurane Revenue by Type
  2. 5.1.1 Global Medical Sevoflurane Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Medical Sevoflurane Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Medical Sevoflurane Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Medical Sevoflurane Sales by Type
  6. 5.2.1 Global Medical Sevoflurane Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Medical Sevoflurane Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Medical Sevoflurane Sales Market Share by Type (2021-2032)
  9. 5.3 Global Medical Sevoflurane Price by Type
6 Medical Sevoflurane Market by Application
  1. 6.1 Global Medical Sevoflurane Revenue by Application
  2. 6.1.1 Global Medical Sevoflurane Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Medical Sevoflurane Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Medical Sevoflurane Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Medical Sevoflurane Sales by Application
  6. 6.2.1 Global Medical Sevoflurane Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Medical Sevoflurane Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Medical Sevoflurane Sales Market Share by Application (2021-2032)
  9. 6.3 Global Medical Sevoflurane Price by Application
7 Company Profiles
  1. 7.1 AbbVie
  2. 7.1.1 AbbVie Company Information
  3. 7.1.2 AbbVie Business Overview
  4. 7.1.3 AbbVie Medical Sevoflurane Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 AbbVie Medical Sevoflurane Product Portfolio
  6. 7.1.5 AbbVie Recent Developments
  7. 7.2 Maruishi
  8. 7.2.1 Maruishi Company Information
  9. 7.2.2 Maruishi Business Overview
  10. 7.2.3 Maruishi Medical Sevoflurane Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Maruishi Medical Sevoflurane Product Portfolio
  12. 7.2.5 Maruishi Recent Developments
  13. 7.3 Piramal
  14. 7.3.1 Piramal Company Information
  15. 7.3.2 Piramal Business Overview
  16. 7.3.3 Piramal Medical Sevoflurane Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Piramal Medical Sevoflurane Product Portfolio
  18. 7.3.5 Piramal Recent Developments
  19. 7.4 PT Novell Pharmaceutical
  20. 7.4.1 PT Novell Pharmaceutical Company Information
  21. 7.4.2 PT Novell Pharmaceutical Business Overview
  22. 7.4.3 PT Novell Pharmaceutical Medical Sevoflurane Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 PT Novell Pharmaceutical Medical Sevoflurane Product Portfolio
  24. 7.4.5 PT Novell Pharmaceutical Recent Developments
  25. 7.5 Viatris
  26. 7.5.1 Viatris Company Information
  27. 7.5.2 Viatris Business Overview
  28. 7.5.3 Viatris Medical Sevoflurane Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Viatris Medical Sevoflurane Product Portfolio
  30. 7.5.5 Viatris Recent Developments
  31. 7.6 Baxter
  32. 7.6.1 Baxter Company Information
  33. 7.6.2 Baxter Business Overview
  34. 7.6.3 Baxter Medical Sevoflurane Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Baxter Medical Sevoflurane Product Portfolio
  36. 7.6.5 Baxter Recent Developments
  37. 7.7 Lunan Pharma
  38. 7.7.1 Lunan Pharma Company Information
  39. 7.7.2 Lunan Pharma Business Overview
  40. 7.7.3 Lunan Pharma Medical Sevoflurane Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Lunan Pharma Medical Sevoflurane Product Portfolio
  42. 7.7.5 Lunan Pharma Recent Developments
  43. 7.8 Hengrui
  44. 7.8.1 Hengrui Company Information
  45. 7.8.2 Hengrui Business Overview
  46. 7.8.3 Hengrui Medical Sevoflurane Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Hengrui Medical Sevoflurane Product Portfolio
  48. 7.8.5 Hengrui Recent Developments
8 North America
  1. 8.1 North America Medical Sevoflurane Market Size by Type
  2. 8.1.1 North America Medical Sevoflurane Revenue by Type (2021-2032)
  3. 8.1.2 North America Medical Sevoflurane Sales by Type (2021-2032)
  4. 8.1.3 North America Medical Sevoflurane Price by Type (2021-2032)
  5. 8.2 North America Medical Sevoflurane Market Size by Application
  6. 8.2.1 North America Medical Sevoflurane Revenue by Application (2021-2032)
  7. 8.2.2 North America Medical Sevoflurane Sales by Application (2021-2032)
  8. 8.2.3 North America Medical Sevoflurane Price by Application (2021-2032)
  9. 8.3 North America Medical Sevoflurane Market Size by Country
  10. 8.3.1 North America Medical Sevoflurane Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Medical Sevoflurane Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Medical Sevoflurane Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Medical Sevoflurane Market Size by Type
  2. 9.1.1 Europe Medical Sevoflurane Revenue by Type (2021-2032)
  3. 9.1.2 Europe Medical Sevoflurane Sales by Type (2021-2032)
  4. 9.1.3 Europe Medical Sevoflurane Price by Type (2021-2032)
  5. 9.2 Europe Medical Sevoflurane Market Size by Application
  6. 9.2.1 Europe Medical Sevoflurane Revenue by Application (2021-2032)
  7. 9.2.2 Europe Medical Sevoflurane Sales by Application (2021-2032)
  8. 9.2.3 Europe Medical Sevoflurane Price by Application (2021-2032)
  9. 9.3 Europe Medical Sevoflurane Market Size by Country
  10. 9.3.1 Europe Medical Sevoflurane Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Medical Sevoflurane Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Medical Sevoflurane Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Medical Sevoflurane Market Size by Type
  2. 10.1.1 China Medical Sevoflurane Revenue by Type (2021-2032)
  3. 10.1.2 China Medical Sevoflurane Sales by Type (2021-2032)
  4. 10.1.3 China Medical Sevoflurane Price by Type (2021-2032)
  5. 10.2 China Medical Sevoflurane Market Size by Application
  6. 10.2.1 China Medical Sevoflurane Revenue by Application (2021-2032)
  7. 10.2.2 China Medical Sevoflurane Sales by Application (2021-2032)
  8. 10.2.3 China Medical Sevoflurane Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Medical Sevoflurane Market Size by Type
  2. 11.1.1 Asia Medical Sevoflurane Revenue by Type (2021-2032)
  3. 11.1.2 Asia Medical Sevoflurane Sales by Type (2021-2032)
  4. 11.1.3 Asia Medical Sevoflurane Price by Type (2021-2032)
  5. 11.2 Asia Medical Sevoflurane Market Size by Application
  6. 11.2.1 Asia Medical Sevoflurane Revenue by Application (2021-2032)
  7. 11.2.2 Asia Medical Sevoflurane Sales by Application (2021-2032)
  8. 11.2.3 Asia Medical Sevoflurane Price by Application (2021-2032)
  9. 11.3 Asia Medical Sevoflurane Market Size by Country
  10. 11.3.1 Asia Medical Sevoflurane Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Medical Sevoflurane Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Medical Sevoflurane Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Medical Sevoflurane Market Size by Type
  2. 12.1.1 SAMEA Medical Sevoflurane Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Medical Sevoflurane Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Medical Sevoflurane Price by Type (2021-2032)
  5. 12.2 SAMEA Medical Sevoflurane Market Size by Application
  6. 12.2.1 SAMEA Medical Sevoflurane Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Medical Sevoflurane Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Medical Sevoflurane Price by Application (2021-2032)
  9. 12.3 SAMEA Medical Sevoflurane Market Size by Country
  10. 12.3.1 SAMEA Medical Sevoflurane Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Medical Sevoflurane Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Medical Sevoflurane Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Medical Sevoflurane Value Chain Analysis
  2. 13.1.1 Medical Sevoflurane Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Medical Sevoflurane Production Mode & Process
  6. 13.2 Medical Sevoflurane Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Medical Sevoflurane Distributors
  9. 13.2.3 Medical Sevoflurane Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.